M33 Growth I L.P.

13D and 13G Filings

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Oncology Institute, Inc. 13D/A Amendment 6 DFPH · 23343Q100	DFPH	23343Q100	4.9%	5,002,656	13D/A Amendment 6	5/15/2026 Event 5/14/2026
M33 Growth I L.P.			4.9%	5,002,656
M33 Growth I GP LLC			4.9%	5,002,656
Toi M, LLC			0%	0
Oncology Institute, Inc. 13D/A Amendment 5 DFPH · 23343Q100	DFPH	23343Q100	5.5%	6,802,656	13D/A Amendment 5	11/20/2025 Event 11/18/2025
M33 Growth I LP			5.5%	6,802,656
M33 Growth I GP LLC			5.5%	6,802,656
Toi M, LLC			0%	0
Oncology Institute, Inc. 13D/A Amendment 4 DFPH · 23343Q100	DFPH	23343Q100	9.8%	9,290,838	13D/A Amendment 4	9/5/2025 Event 9/4/2025
M33 Growth I LP			9.8%	9,290,838
M33 Growth I GP LLC			9.8%	9,290,838
Toi M, LLC			0.6%	590,892
The Oncology Institute, Inc. 13D/A Amendment 3 DFPH · 23343Q100	DFPH	23343Q100	20.0%	17,543,172	13D/A Amendment 3	3/28/2025 Event 3/26/2025
M33 Growth I LP			20.0%	17,543,172
M33 Growth I GP LLC			20.0%	17,543,172
Toi M, LLC			1.8%	1,552,580

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.